| Name / ID | Type | Disease | RRID | Causal gene(s) | Mutation | Originating lab |
|---|---|---|---|---|---|---|
| SCA7 10Q | Cell Lines | SCA7 | — |
ATXN7 | 10 CAG induced from ATXN7 KO | University of Califorania |
| SCA7 113Q | Cell Lines | SCA7 | — |
ATXN7 | 113 CAG induced from ATXN7 KO | University of Califorania |
| SCA7 KO | Cell Lines | SCA7 | — |
ATXN7 | ATXN7 Knock-out | University of Califorania |
| SCA7-1 | Cell Lines | SCA7 | — |
ATXN7 | — | Brigham and women's Hospital |
| SCA7-2 | Cell Lines | SCA7 | — |
ATXN7 | — | Brigham and women's Hospital |
| SCD16 | Cell Lines | SCA6 | CVCL_RJ10 |
CACNA1A | 22/12 CAG | RIKEN Center for Developmental Biology |
| SCD162 | Cell Lines | SCA6 | — |
CACNA1A | 23/23 CAG | RIKEN Center for Developmental Biology |
| SCD162-6-2,13-2,17-2 | Cell Lines | SCA6 | CVCL_RJ04, CVCL_RJ05, CVCL_RJ06 |
CACNA1A | 23/23 CAG | RIKEN Center for Developmental Biology |
| SCD166 | Cell Lines | SCA6 | — |
CACNA1A | 26/14 CAG | RIKEN Center for Developmental Biology |
| SCD166-2-3,2-14,2-16 | Cell Lines | SCA6 | CVCL_RJ07, CVCL_RJ08, CVCL_RJ09 |
CACNA1A | 26/14 CAG | RIKEN Center for Developmental Biology |
| Setx-/- | Mouse Models | AOA2/SCAN2/SCAR1 | — |
SETX | Homozygous Setx knock-out mice | University of Queensland |
| SK.01AiPS | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | c.9284dupC (homozygous) | Obtained from: McGill University |
| SK10A | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | c.9248dupC/p.Ala3096Cysfs*2 | Obtained from: Queen Mary University of London |
| SN-2C | Cell Lines | SCA12 | — |
PPP2R2B | 73/14 CAG; CRISPR/Cas9n modified line from CS25i-18n2 / SN-2 (isogenic pair) | Johns Hopkins University |
| Spg7-/- mice | Mouse Models | SPG7 | — |
SPG7 | Spg7 homozygous knockout | Telethon Institute of Genetics and Medicine |
| Spg7−/−Afg3l2Emv66/+ mice | Mouse Models | SPG7 | — |
SPG7 | Spg7 homozygous knockout and heterozygous Afg3l2 mice | Istituto Neurologico C. Besta |
| SZ-FX10 | Cell Lines | FXTAS | CVCL_Y331 |
FMR1 | >58 and <200 CGG (heterozygous; premutation carrier) | Shaare Zedek Medical Center (SZMC) |
| SZ-FX11 | Cell Lines | FXTAS | CVCL_YL34 |
FMR1 | >58 CGG (premutation carrier) | Shaare Zedek Medical Center (SZMC) |
| SZ-FX13 | Cell Lines | FXTAS | CVCL_YL36 |
FMR1 | >58 CGG (premutation carrier) | Shaare Zedek Medical Center (SZMC) |
| SZ-FX16 | Cell Lines | FXTAS | CVCL_YL38 |
FMR1 | >58 CGG (premutation carrier) | Shaare Zedek Medical Center (SZMC) |
| SZ-FX22 | Cell Lines | FXTAS | CVCL_YL41 |
FMR1 | >58 CGG (premutation carrier) | Shaare Zedek Medical Center (SZMC) |
| SZ-FX5 | Cell Lines | FXTAS | CVCL_YL43 |
FMR1 | >58 and <200 CGG (heterozygous; premutation carrier) | Shaare Zedek Medical Center (SZMC) |
| TA1628 | Cell Lines | SCA10 | — |
ATXN10 | — | Fred Hutchinson Cancer Research Center |
| Tdp1-/-;Aptx-/- mice | Mouse Models | AOA1 | — |
APTX | Tdp1 and Aptx homozygous knockout mice | University of Sussex |
| TgM83+/− Snca+/+ | Mouse Models | MSA/OPCA | — |
Sporadic | human A53T α-synuclein (heterozygous) and mouse α-synuclein (homozygous) | University of California |
| TgM83+/− Snca0/+ | Mouse Models | MSA/OPCA | — |
Sporadic | human A53T α-synuclein (heterozygous) and mouse α-synuclein (heterozygous KO) | University of California |
| TgM83+/− Snca0/0 | Mouse Models | MSA/OPCA | — |
Sporadic | human A53T α-synuclein (heterozygous) and mouse α-synuclein (homozygous KO) | University of California |
| Thy-1 αSYN mice (Line 61) | Mouse Models | MSA/OPCA | — |
Sporadic | WT and mutant (A30P) human α-synuclein | University of California |
| Tk2-/- KO mice (no ataxia phenotype) | Mouse Models | SCA31 | — |
BEAN1/TK2 | Homozygous Tk2 knock-out mice | Karolinska Institute |
| Transgenic DRPLA 113Q Mice | Mouse Models | DRPLA | — |
ATN1 | 113Q | The University of Tokyo |
| Transgenic DRPLA 129Q Mice | Mouse Models | DRPLA | — |
ATN1 | 129Q | Niigata University |
| Transgenic DRPLA 76Q Mice | Mouse Models | DRPLA | — |
ATN1 | Q76 | Niigata University |
| Transgenic DRPLA 96Q Mice | Mouse Models | DRPLA | — |
ATN1 | 96Q | The University of Tokyo |
| TRE-90CGG-eGFP mice | Mouse Models | FXTAS | — |
FMR1 | Inducible transgenic mouse model that express 90 CGG | Erasmus Medical Center |
| TTBK2 knockin mice | Mouse Models | SCA11 | — |
TTBK2 | Heterozygous TTBK2 knock-in of one-base insertion in exon 13 at nucleotide 1329 | University of Dundee |
| TVGH-iPSC-003-12 | Cell Lines | SCA3 | CVCL_QY11 |
ATXN3 | — | Tapei Veterans General Hospital |
| TVGH-iPSC-SCA3-04 | Cell Lines | SCA3 | CVCL_JL89 |
ATXN3 | ? | Tapei Veterans General Hospital |
| UKBi001-B | Cell Lines | SCA3 | CVCL_W573 |
ATXN3 | 74/21 CAG | Universitätsklinikum Bonn (UKB) |
| UKBi003-A | Cell Lines | SCA3 | CVCL_W571 |
ATXN3 | 74/22 CAG | Universitätsklinikum Bonn (UKB) |
| UM300-1 PGD | Cell Lines | SCA3 | CVCL_C3FA |
ATXN3 | — | University of Michigan |
| UM300-2 PGD | Cell Lines | SCA3 | CVCL_C3FB |
ATXN3 | — | University of Michigan |
| UMICHe001-A | Cell Lines | SCA3 | CVCL_X365 |
ATXN3 | 70/13 CAG | University of Michigan |
| UMICHi001-A | Cell Lines | SCA15/16 | — |
ITPR1 | Parental line, no mutations present, used for CRISPRing UMICHi001-A-2 line | The University of Michigan |
| UMICHi001-A-2 | Cell Lines | SCA15/16 | — |
ITPR1 | CRISPRed line from parental line UMICHi001-A; ITPR1-/+ Heterozygous knock-out | The University of Michigan |
| UNIFEi001-A | Cell Lines | SCA1 | CVCL_E6MA |
ATXN1 | 29/60 CAG | University of Ferrara (UNIFE) |
| UNIFEi002-A | Cell Lines | SCA1 | — |
ATXN1 | — | University of Ferrara (UNIFE) |
| UNIFEi004-A | Cell Lines | SCA1 | — |
ATXN1 | — | University of Ferrara (UNIFE) |
| UT | Cell Lines | MSA/OPCA | — |
? | Unaffected monozygotic twin of C1 (MSA-C) | University of Milan |
| VUBe010-A | Cell Lines | SCA7 | CVCL_9847 |
ATXN7 | 10/37 CAG | Vrije Universiteit Brussel |
| WAe001-A-50 | Cell Lines | FXTAS | CVCL_C0CC |
FMR1 | CRISPR/Cas9 generated FMR1 KO | University of Wisconsin |
Twenty Twenty-Five
Designed with WordPress